High-dose atorvastatin versus moderate dose on early vascular protection after ST-elevation myocardial infarction
Mara Gavazzoni,1 Elio Gorga,1 Giuseppe Derosa,2–5 Pamela Maffioli,2,4 Marco Metra,1 Riccardo Raddino1 1Cardiology Department, University of Brescia, Spedali Civili di Brescia, Brescia, 2Centre of Diabetes and Metabolic Diseases, Department of Internal Medicine and Therapeutics, University...
Saved in:
Main Authors: | Gavazzoni M (Author), Gorga E (Author), Derosa G (Author), Maffioli P (Author), Metra M (Author), Raddino R (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2017-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
MONITORING OF THE EFFICACY AND SAFETY OF HIGH-DOSE ATORVASTATIN IN ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION
by: L. I. Salyamova, et al.
Published: (2018) -
Dose-dependent effects of atorvastatin on myocardial infarction
by: Barbarash O, et al.
Published: (2015) -
Nephroprotective effect of atorvastatin at a dose of 80 mg in patients with ST-segment elevation myocardial infarction with an invasive treatment strategy
by: A. D. Gavrilko, et al.
Published: (2023) -
Effects of High-Dose Rosuvastatin on Ventricular Remodelling and Cardiac Function in ST-Segment Elevation Myocardial Infarction
by: Luo R, et al.
Published: (2020) -
Early Effects of Treatment Low-dose Atorvastatin on Markers of Insulin Resistance and Inflammation in Patients with Myocardial Infarction
by: Olga Gruzdeva, et al.
Published: (2016)